Christina Haeyoung Yeon, M.D., M.H.M.

Location
South Pasadena
South Pasadena, CA 91030
Education & Experience
2015, American Board of Internal Medicine — Subspecialty of Hematology
2014, American Board of Internal Medicine — Subspecialty of Medical Oncology
2001, American Board of Internal Medicine
2022, Masters of Healthcare Management (M.H.M), Eller College of Management, University of Arizona, Tucson, AZ
1998, M.D., UCLA, Los Angeles, CA
1994, B.S., biochemistry, Summa Cum Laude, UCLA, Los Angeles, CA
2001-2004, Fellow, Hematology/Oncology, UCLA, Los Angeles, CA
1999-2001, Resident, Internal Medicine, UCLA, Los Angeles, CA
1998-1999, Intern, Internal Medicine, UCLA, Los Angeles, CA
2019-present, Associate Clinical Professor, Department
of Medical Oncology & Therapeutics Research, City of Hope, South Pasadena and Duarte, CA2018-present, Regional Director for San Gabriel Valley, City of Hope, South Pasadena, CA
2011-2019, Assistant Clinical Professor, Department
of Medical Oncology & Therapeutics Research, City of Hope, South Pasadena, CA2004-2011, Physician, Wilshire Oncology Medical Group Inc., Pasadena, CA
Awards & Memberships
Memberships
American Society of Clinical Oncology
Publications
-
Lavasani SM, Somlo G, Yost SE, Frankel PH, Ruel C, Cui Y, Murga M, Tang A, Martinez N, Kruper L, Tumyan L, Schmolze D, Yeon C, Yuan Y, Waisman JR, Mortimer J. Phase 2 prospective open label study of neoadjuvant nab-paclitaxel, trastuzumab, and pertuzumab in patients with HER2-positive primary breast cancer. Cancer. 2022 Dec 14. DOI: 10.1002/cncr.34589.
-
Bosserman LD, Cianfrocca M, Yuh B, Yeon C, Chen H, Sentovich S, Polverini A, Zachariah F, Deaville D, Lee A, Sedrak M, King E, Gray S, Morse D, Glaser S, Bhatt G, Adeimy C, Tan T, Chao J, Nam A, Paz I, Kruper L, Rao P, Sokolov K, Kulkarni P, Salgia R, Yamzon J, Johnson D. Integrating academic and community cancer care and research through multidisciplinary oncology pathways for value-based care: a review and the City of Hope experience. J Clin Med. 2021 Jan 7;10(2):188. DOI: 10.3390/jcm10020188.
-
Yuan Y, Lee JS, Yost SE, Li SM, Frankel PH, Ruel C, Schmolze D, Robinson K, Tang A, Martinez N, Stewart D, Waisman J, Kruper L, Jones V, Menicucci A, Uygun S, Yoder E, van der Baan B, Yim JH, Yeon C, Somlo G, Mortimer J. Phase II trial of neoadjuvant carboplatin and nab-paclitaxel in patients with triple-negative breast cancer. Oncologist. 2020 Oct 24. DOI: 10.1002/onco.13574.
-
Mortimer JE, Kruper L, Cianfrocca M, Lavasani S, Liu S, Tank-Patel N, Sedrak M, Smith W, Stewart D, Waisman J, Yeon C, Wang T, Yuan Y. Use of HER2-directed therapy in metastatic breast cancer and how community physicians collaborate to improve care. J Clin Med. 2020 June 24;9(6):1984. DOI: 10.3390/jcm9061984.
-
Liu J, Gutierrez E, Tiwari A, Padam S, Li D, Dale W, Pal SK, Stewart D, Subbiah S, Bosserman LD, Presant C, Phillips T, Yap K, Hill A, Bhatt G, Yeon C, Cianfrocca M, Yuan Y, Mortimer J, Sedrak MS. Strategies to improve participation of older adults in cancer research. J Clin Med. 2020 May 22; 9(5): 1571. DOI: 10.3390/jcm9051571.
-
Hurria A, Soto Perez de Celis E, Blanchard S, Burhenn P, Yeon C, Yuan Y, Li D, Katheria V, Waisman JR, Luu TH, Somlo G, Noonan AM, Lee T, Sudan N, Chung S, Rotter A, Arsenyan A, Levi A, Mortimer JE. A phase II trial of older adults with metastatic breast cancer receiving nab-paclitaxel: melding the fields of geriatrics and oncology. Clin Breast Cancer. 2019 Apr; 19(2): 89-96. DOI: 10.1016/j.clbc.2018.10.002.
-
Ashing KT, Cho D, Lai L, Yeung S, Young L, Yeon C, Fong Y. Exploring characteristics, predictors, and consequences of fear of cancer recurrence among Asian-American breast cancer survivors. Psycho-Oncology. 2017 Dec; 26(12): 2253-2260. DOI: 10.1002/pon.4350.
-
Chung V, Frankel P, Lim D, Yeon C, Leong L, Chao J, Ruel N, Luevanos E, Koehler S, Chung S, Lau SC, Fakih MG. Phase Ib trial of mFOLFOX6 and everolimus (NSC-733504) in patients with metastatic gastroesophageal adenocarcinoma. Oncology 2016 Apr 20, 90(6): 307-312. DOI: 10.1159/000445297.
- Lai L, Woo D, Chapman Y, Sudan N, Yeon CH, Trisal V and Waisman JR. Mismatch of available cancer therapeutic trials to patient populations in community practices [abstract]. In: Proc Am Soc Clin Oncol; 2014. Abstract 84.
- Chung V, Frankel P, Lim D, Chao J, Yeon CH, Leong L, Kim J, Luevanos E, Rose C and Fakih M. A phase 1b trial of mFOLFOX6 and everolimus (NSC-733504) in patients with metastatic gastroesophageal adenocarcinoma (NCT01231399) [abstract]. In: Proc Am Soc Clin Oncol; 2014. Abstract e15007.